Fri, May
52 New Articles

Kinstellar Advises Novavax on Acquisition of Praha Vaccines from Cyrus Poonawalla Group

Kinstellar Advises Novavax on Acquisition of Praha Vaccines from Cyrus Poonawalla Group

Czech Republic
  • Smaller Small Medium Big Bigger
  • Default Helvetica Segoe Georgia Times

Kinstellar has advised US-based Novavax, a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, on its acquisition of Praha Vaccines a.s. from the Cyrus Poonawalla Group.

The acquisition includes a vaccine and biologics manufacturing facility and other support buildings in the Czech city of Jevany, together with the company’s employees and all related infrastructure. The value of the transaction was approximately USD 167 million.

According to Kinstellar, "the newly acquired facility is expected to provide an annual production capacity of over 1 billion doses of antigen starting in 2021 for NVX‑CoV2373 — Novavax’s COVID-19 vaccine candidate. The acquisition of Praha Vaccines is supported by Novavax’s funding arrangement with the Coalition for Epidemic Preparedness Innovations, which enables Novavax to dramatically expand its manufacturing capacity."

The Kinstellar team was led by Partner Jan Juroska and included Partner Tomas Cihula, Associates Martina Mazurkova and Martin Holub, and Junior Associates Matej Vecera, Stepanka Havlikova, Alice Radvanovska, Veronika Roznovska, and Sabina Skoumalova.

Kinstellar did not reply to our inquiry on the matter.

Czech Republic Knowledge Partner

PRK Partners, one of the leading Central European law firms, has been helping clients achieve their business objectives almost 30 years. Our team of lawyers, based in our Prague, Ostrava, and Bratislava offices, has a unique knowledge of Czech and Slovak law and of the business environment. Our lawyers studied at top law schools in the United States, United Kingdom, Switzerland and elsewhere. They also have experience working for leading international and domestic law firms in a number of jurisdictions. We speak your language, too. Our legal team is fluent in more than 15 languages, including all the key languages of the region.

PRK Partners has one of the most experienced legal teams on the market. We are consistently rated as one of the leading law firms in the region. We have received many significant honours and awards for our work. We represent the interests of international clients operating in the Czech Republic in an efficient way, combining local knowledge with an understanding of their global requirements in a business-friendly approach. We are one of the largest law firms in the Czech Republic and Slovakia. Our specialised teams of lawyers and tax advisors advise major global corporations as well as local companies. We provide comprehensive legal advice drawing on our profound knowledge of local law and markets.

Our legal advice delivers tangible results – as proven by our strong track record. We are the only Czech member firm of Lex Mundi, the world's leading network of independent law firms. As one of the leading law firms in the region, we have received many national and international awards, in some cases several years in a row. Honours include the Chambers Europe Award for Excellence, The Lawyer and Czech and Slovak Law Firm of the Year. Thanks to our close cooperation with leading international law firms and strong local players, we can serve clients in multiple jurisdictions around the globe. Our strong network means that we can meet your needs, wherever you do business.

PRK Partners has been repeatedly voted among the most socially responsible firms in the category of small and mid-sized firms and was awarded the bronze certificate at the annual TOP Responsible Firm of the Year Awards.

Our work is not only “business”: we have participated on a longstanding basis in a wide variety of pro bono projects and supported our partners from the non-profit sector (Kaplicky Centre Endowment Fund, Tereza Maxová Foundation, Czech Donors Forum, etc.).

Firm's website: www.prkpartners.com

Our Latest Issue